We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$251M
AUM Growth
-$19M
Cap. Flow
-$2.24M
Cap. Flow %
-0.89%
Top 10 Hldgs %
7.1%
Holding
477
New
43
Increased
256
Reduced
137
Closed
41

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$962K
2
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$944K
3
ENPH icon
Enphase Energy
ENPH
+$834K
4
DVN icon
Devon Energy
DVN
+$751K
5
IT icon
Gartner
IT
+$742K

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$785K
2
LHX icon
L3Harris
LHX
+$740K
3
A icon
Agilent Technologies
A
+$713K
4
CPRT icon
Copart
CPRT
+$688K
5
CQP icon
Cheniere Energy
CQP
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 18.83%
2 Real Estate 17.55%
3 Materials 12.77%
4 Financials 9.88%
5 Energy 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABCL icon
401
AbCellera Biologics
ABCL
$1.69B
$117K 0.05%
11,876
+92
+0.8% +$1.01K
CRSP icon
402
CRISPR Therapeutics
CRSP
$4.69B
$117K 0.05%
1,795
+11
+0.6% +$797
GHRS icon
403
GH Research
GHRS
$1.94B
$117K 0.05%
10,026
+74
+0.7% +$933
PNT
404
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$117K 0.05%
15,135
+106
+0.7% +$900
SRNE
405
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$116K 0.05%
74,087
+540
+0.7% +$1.23K
KOD icon
406
Kodiak Sciences
KOD
$2.53B
$113K 0.05%
14,555
+102
+0.7% +$991
NKTX icon
407
Nkarta
NKTX
$155M
$113K 0.05%
8,576
+62
+0.7% +$887
CGEM icon
408
Cullinan Oncology
CGEM
$1.05B
$111K 0.04%
8,686
+66
+0.8% +$889
ITOS
409
DELISTED
iTeos Therapeutics
ITOS
$111K 0.04%
5,828
+38
+0.7% +$875
ZYME icon
410
Zymeworks
ZYME
$1.63B
$111K 0.04%
17,980
+132
+0.7% +$796
NGM
411
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$109K 0.04%
8,327
+64
+0.8% +$969
ATAI icon
412
AtaiBeckley Inc
ATAI
$2.66B
$107K 0.04%
32,341
+235
+0.7% +$965
CION icon
413
CION Investment
CION
$302M
$107K 0.04%
+12,643
New +$119K
BXSL icon
414
Blackstone Secured Lending
BXSL
$5.4B
$106K 0.04%
+4,676
New +$112K
MRUS
415
DELISTED
Merus
MRUS
$105K 0.04%
5,220
+37
+0.7% +$883
DVAX
416
DELISTED
Dynavax Technologies
DVAX
$104K 0.04%
9,970
+66
+0.7% +$860
KURA icon
417
Kura Oncology
KURA
$811M
$104K 0.04%
7,650
+58
+0.8% +$895
TIL icon
418
Instil Bio
TIL
$48.9M
$104K 0.04%
1,070
+7
+0.7% +$801
ZNTL icon
419
Zentalis Pharmaceuticals
ZNTL
$333M
$104K 0.04%
4,819
+33
+0.7% +$902
ARQT icon
420
Arcutis Biotherapeutics
ARQT
$3.51B
$101K 0.04%
5,275
+43
+0.8% +$974
MDGL icon
421
Madrigal Pharmaceuticals
MDGL
$12.5B
$99K 0.04%
1,519
+15
+1% +$1.04K
AFMD
422
DELISTED
Affimed
AFMD
$95K 0.04%
4,601
+33
+0.7% +$917
RPTX
423
DELISTED
Repare Therapeutics
RPTX
$93K 0.04%
7,637
+51
+0.7% +$656
VIR icon
424
Vir Biotechnology
VIR
$1.47B
$91K 0.04%
4,695
+36
+0.8% +$915
RETA
425
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$91K 0.04%
3,604
+25
+0.7% +$693
15 16
17
18 19

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Virtus ETF Advisers held 477 positions worth $251M, down 7% from $270M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Virtus ETF Advisers's Q3 2022 filing shows 43 new, 256 increased, 137 reduced and 41 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K. The largest sale was Moderna, an estimated $785K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Real Estate and Materials.

  • Virtus ETF Advisers's largest Q3 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K.
  • Virtus ETF Advisers added most to The Mosaic Company in Q3 2022, an estimated $962K increase.
  • Virtus ETF Advisers's biggest Q3 2022 reduction was Moderna, cutting an estimated $785K.
  • Virtus ETF Advisers fully exited L3Harris in Q3 2022, selling an estimated $740K.
  • Virtus ETF Advisers's ten largest holdings make up 7.1% of its $251M portfolio in Q3 2022.
  • Virtus ETF Advisers opened 43 new positions and closed 41 in Q3 2022.
  • Virtus ETF Advisers's portfolio value fell 7% quarter-over-quarter to $251M.

Based on Virtus ETF Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.